SLC12A5 and neoplasm: Then, we investigated the clinical significances of SLC12A5 in pan-cancers, and we noticed that SLC12A5 was higher in advanced tumor stages of COAD, ESCA, and KIRC, while it was lower in advanced tumor stages of PAAD, READ, and TGCT.